Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.91M Sell
5,062
-6,217
-55% -$2.66M 0.01% 667
2025
Q4
$4.83M Buy
11,279
+6,749
+149% +$2.94M 0.02% 542
2025
Q3
$2.03M Buy
4,530
+1,690
+60% +$765K 0.01% 723
2025
Q2
$1.38M Sell
2,840
-4,827
-63% -$2.75M 0.01% 449
2025
Q1
$4.72M Sell
7,667
-682
-8% -$388K 0.02% 369
2024
Q4
$4.42M Sell
8,349
-12,207
-59% -$6.88M 0.02% 359
2024
Q3
$12.4M Sell
20,556
-8,266
-29% -$4.69M 0.07% 232
2024
Q2
$15.6M Buy
28,822
+21,620
+300% +$12.4M 0.08% 185
2024
Q1
$4.62M Sell
7,202
-7,400
-51% -$4.5M 0.02% 386
2023
Q4
$8.54M Sell
14,602
-2,955
-17% -$1.65M 0.05% 268
2023
Q3
$9.12M Buy
17,557
+1,496
+9% +$778K 0.06% 250
2023
Q2
$8.7M Sell
16,061
-1,978
-11% -$1.08M 0.05% 217
2023
Q1
$9.7M Sell
18,039
-4,943
-22% -$2.52M 0.06% 207
2022
Q4
$11.7M Sell
22,982
-3,613
-14% -$1.76M 0.06% 227
2022
Q3
$11.6M Buy
26,595
+5,007
+23% +$2.41M 0.06% 230
2022
Q2
$10.1M Sell
21,588
-2,139
-9% -$1.04M 0.04% 328
2022
Q1
$12M Buy
23,727
+5,886
+33% +$2.82M 0.05% 258
2021
Q4
$9.44M Buy
17,841
+1,531
+9% +$735K 0.05% 201
2021
Q3
$7.59M Buy
16,310
+452
+3% +$213K 0.04% 234
2021
Q2
$7.53M Buy
15,858
+9,616
+154% +$4.62M 0.05% 263
2021
Q1
$2.87M Sell
6,242
-2,894
-32% -$1.42M 0.03% 256
2020
Q4
$4.87M Buy
9,136
+5,136
+128% +$2.52M 0.04% 200
2020
Q3
$1.92M Buy
+4,000
New +$1.96M 0.02% 266

Other funds holding CHE

Ray Dalio's CHE Position: Q1 2026 in Review

Ray Dalio reduced its Chemed (CHE) stake by 55% in Q1 2026, selling an estimated $2.66M and leaving 5,062 shares worth $1.91M. The position accounts for 0.01% of the portfolio, ranked #667.

Ray Dalio first reported a position in CHE in Q3 2020 and has held it in 23 quarters since. The position peaked at $15.6M in Q2 2024. 490 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • Ray Dalio held 5,062 shares of Chemed worth $1.91M as of Q1 2026.
  • Ray Dalio sold 6,217 Chemed shares in Q1 2026, an estimated $2.66M.
  • Chemed made up 0.01% of Ray Dalio's portfolio in Q1 2026, its #667 holding.
  • Ray Dalio first reported a position in Chemed in Q3 2020 and has held it in 23 quarters since.
  • Ray Dalio's Chemed position peaked at $15.6M in Q2 2024.
  • 490 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.